Dashan Ai

机构：Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center, Shanghai Clinical Research Center, Alibaba Group (China) · ORCID：0000-0002-2599-8861

发表论文 55 篇 · 总被引 822 次 · h-index 13

代表论文

• Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial (2023 · ˜The œLancet. Gastroenterology & hepatology · 被引 82)
• Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trial (2024 · EClinicalMedicine · 被引 33)
• Radiotherapy for Advanced Esophageal Cancer: from Palliation to Curation (2023 · Current Treatment Options in Oncology · 被引 22)
• Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials (2023 · The Oncologist · 被引 18)
• Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs (2023 · Radiation Oncology · 被引 17)
• Radiation Dose–Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy (2025 · Clinical Cancer Research · 被引 8)